Bio-Light Israeli Life Sciences Investments Ltd. (TASE:BOLT) today announced that a foreign investor, whose name it did not disclose, has invested NIS 10.5 million in the company at NIS 0.35 per share, receiving 30 million shares, 11.26% of the company, in exchange.
Bio-Light's share price rose 12.5% by midday to NIS 0.324, giving a market cap of NIS 48 million.
Bio-Light CEO Suzana Nahum Zilberberg said, "This is another vote of confidence in our strategy and the large added value in our cluster model, which aims to create value through the sharing of knowledge and economies of scale."
Bio-Light's portfolio companies include IOptima Ltd., which is developing a treatment for glaucoma, and cancer diagnostics developer Zetiq Technologies Ltd.
Published by Globes [online], Israel business news - www.globes-online.com - on July 12, 2011
© Copyright of Globes Publisher Itonut (1983) Ltd. 2011